Panbio COVID-19 Ag Rapid Test Device - User Product Training FOR EXTERNAL USE
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Panbio™ COVID-19 Ag Rapid Test Device • In vitro diagnostic rapid test for qualitative detection of SARS-CoV-2 antigen (Ag) • Detects nucleocapsid protein inside the SARS-CoV-2 virus 2
Intended Use Panbio™ COVID-19 Ag Rapid Test Device is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasopharyngeal swab specimens from individuals who meet COVID-19 clinical and/or epidemiological criteria. Panbio™ COVID-19 Ag Rapid Test Device is for professional use only and is intended to be used as an aid in the diagnosis of SARS-CoV-2 infection. The product may be used in any laboratory and non-laboratory environment that meets the requirements specified in the Instructions for Use and local regulation. The test provides preliminary test results. Negative results don’t preclude SARS-CoV-2 infection and they cannot be used as the sole basis for treatment or other management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information. The test is not intended to be used as a donor screening test for SARS-CoV-2. 3
Product Information Cat No/REF: 41FK10 Sample Type: Nasopharyngeal swab Quantity: 25 tests/kit Storage: 2-30°C Shelf Life: 12 months Test Time: 15 minutes do not read results after 20 minutes Multiple Language IFU: English Italian German Portuguese Spanish Russian French 4
Kit Contents: Everything Needed to Run a Test MATERIALS PROVIDED REQUIRED BUT NOT PROVIDED • 25 Test devices with desiccant in • Personal protective equipment (PPE) individual foilpouch • Protective gloves • 1 Buffer (1 x 9 ml/bottle) • Timer • 25 Extraction tubes • Biohazard container • 25 Extraction tube caps • 25 Sterilized nasopharyngeal swabs for sample collection • 1 Positive control swab • 1 Negative control swab • 1 Tube rack • 1 Quick reference guide (Nasopharyngeal) • 1 Instructions for use 5
Specifications PERFORMANCE • Sensitivity: 91.4% (94.1% for samples with Ct values ≤33) • Specificity: 99.8% SPECIFICATIONS • Test time: 15 minutes (do not read results after 20 minutes) • Storage: 2°C–30°C • CE Mark • WHO EUL • Sample Type: Nasopharyngeal swab 6
Test Preparation Read instructions prior to using the Panbio COVID-19 Ag test kit. Comply with personal safety guidelines including the use of personal protective equipment. Collect all items required for running a test. Allow all components to come to room temperature (15 - 30◦C) before use. 7
Test Preparation Check expiry date on the back of the test device pouch. Assure pouch is not damaged. Remove test device from pouch just before testing. Place on a flat surface and write patient ID on device
Test Preparation Hold buffer bottle vertically to dispense buffer fluid into the extraction tube to the marked line (about 300µl) If multiple extraction tubes are in tube rack, label the extraction tube. Place the extraction tube into the provided tube rack. 9
Sample Collection Using the nasopharyngeal swab provided in test kit, collect the sample as shown. ** Gently rub and roll swab 3 – 4 times. Leave swab in place for a few seconds before removing slowly. Place the swab into the extraction tube immediately. ** If a training reference is needed for the nasopharyngeal swab technique, one can be found here from the New England Journal of Medicine: https://www.nejm.org/doi/full/10.1056/NEJMvcm2010260 10
Test Procedure Swirl the swab tip in the buffer fluid, pushing into side of extraction tube, at least 5 times. Squeeze the swab against the extraction tube wall with your fingers. Break the swab at breakpoint as shown and close cap. 11
Test Procedure Open the dropping nozzle cap and add 5 drops of sample vertically into sample well of test device. Close nozzle with cap and dispose the extraction tube into biohazard waste. Start a timer for 15 minutes to read the test result. DO NOT read after 20 minutes. 12
Simple Results Interpretation Invalid NOTE: the presence of any test line (T), no matter how faint, indicates a positive result. 13
Full Test Method 14
Test Limitations Reminder 1. The contents of this kit are to be used for the professional and qualitative detection of SARS-CoV-2 antigen from a nasopharyngeal swab sample. Other specimen types may lead to incorrect results and must not be used. 2. Failure to follow the instructions for the test procedure and interpretation of test results may adversely affect test performance and/or produce invalid results. 3. A negative test result may occur if the specimen was collected, extracted or transported improperly. A negative test result does not eliminate the possibility of SARS-CoV-2 infection and should be confirmed by viral culture or a molecular assay or ELISA. 4. Positive test results do not rule out co-infections with other pathogens. 5. For further information on immune status, additional follow-up testing using other laboratory methods is recommended. 6. Test results must be evaluated in conjunction with other clinical data available to the physician. 7. Reading the test results earlier than 15 minutes or later than 20 minutes may give incorrect results. 8. Panbio™ COVID-19 Ag Rapid Test Device is not intended to detect from defective (non-infectious) virus during the later stages of viral shedding that might be detected by PCR molecular tests. 15
Quality Control INTERNAL Control line (C) on the test device is a procedural control and indicates the procedure is performed properly and reagents are working. EXTERNAL Controls provided in test kit should be used to: - Verify user can perform test and interpret results correctly - Ensure test reagents are working and test performed correctly It is recommended to run controls: - With each new operator prior to testing on patient samples - When receiving a new shipment - At periodic intervals according to local Regulations 16
Key Points to Remember • Follow instructions for use, in order to achieve accurate results • Prepare all test components before specimen collection • Always wear personal protective equipment including protective gloves when handling specimens • Ensure the correct amount of buffer is added to extraction tube • Only use dedicated nasopharyngeal swabs provided for sample collection • Test devices are single use only • Treat all specimens as potentially infectious samples • Discard all items into appropriate biohazard containers • Do not mix components of the test kits
© 2020 Abbott. All rights reserved. All trademarks referenced are trademarks of either the Abbott group of companies or their respective owners. Any photos displayed are for illustrative purposes only. Any person depicted in such photos is a model. 120007278-01 10/20
You can also read